Which patients with renal cancer may benefit from sunitinib therapy?
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 2, p. 69, doi. 10.1177/1758834009359411
- By:
- Publication type:
- Article
Works matching IS 17588340 AND DT 2010 AND VI 2 AND IP 2
Results: 5
1
2
Predictive and prognostic molecular markers for cancer medicine.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 2, p. 125, doi. 10.1177/1758834009360519
- By:
- Publication type:
- Article
3
Renal cell carcinoma bone metastases: clinical advances.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 2, p. 75, doi. 10.1177/1758834009358417
- By:
- Publication type:
- Article
4
Systemic therapy for metastatic pancreatic adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 2, p. 85, doi. 10.1177/1758834009357188
- By:
- Publication type:
- Article
5
Redefining hormone resistance in prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 2, p. 107, doi. 10.1177/1758834009356433
- By:
- Publication type:
- Article